Company intelligence / Profile preview

Opscidia

Paris, Île-de-France, Franceopscidia.com ↗

Ownership: Private
Development stage: Other

Overview

Opscidia offers an artificial intelligence-driven platform that centralizes, analyzes, and synthesizes vast amounts of scientific literature to support R&D teams in the pharmaceutical industry. The platform enables users to monitor trends, generate summaries of research articles, collaborate on projects, detect emerging technologies via weak signals in publications data, and optimize bibliographic research workflows. It has been adopted by organizations such as the European Commission’s Future and Emerging Technology team.

Industry: Drug Discovery Services

Partnerships

European Commission Future & Emerging Technologies teamOpenAIRE public data warehouse projectCap Digital cluster member/labelled French Tech Seed startup

Beyond the preview

Go deeper on Opscidia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opscidia.

Explore the full profile